Glenmark Pharmaceuticals LimitedNSE: GLENMARK

Glenmark Pharmaceuticals Limited Press Release Jul 02 2026

· Issued by Glenmark Pharmaceuticals Limited via NSE India

Filed with NSE · · 3 pages · English

On 6ix: 6ix.com/news/glenmark-pharmaceuticals-limited-press-release-jul-02-2026

Release

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 02, 2026, titled "Glenmark Advances Multi-Country Phase 3 Clinical Trial of Trastuzumab rezetecan in Platinum-Resistant Ovarian Cancer".

Glenmark Pharmaceuticals Limited on 6ix

Earlier from Glenmark Pharmaceuticals

Later from Glenmark Pharmaceuticals

All Glenmark Pharmaceuticals news releases